CENCORA Trademark

Trademark Overview


On Monday, January 23, 2023, a trademark application was filed for CENCORA with the United States Patent and Trademark Office. The USPTO has given the CENCORA trademark a serial number of 97765090. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 6, 2024. This trademark is owned by AmerisourceBergen Corporation. The CENCORA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical analysis services; Medical analysis services, namely, analyzing and reporting in the field of human disease treatment; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services; providing clinical and home health care services, namely, providing ...
cencora

General Information


Serial Number97765090
Word MarkCENCORA
Filing DateMonday, January 23, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesMedical analysis services; Medical analysis services, namely, analyzing and reporting in the field of human disease treatment; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing medical provider and care information; providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; information services for the pharmaceutical and medical sectors; counseling services related to workplace and personnel health; healthcare services; services of information on medical substances; analysing and reporting of discussions about human disease treatment; administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable information and analysis about legislative regulatory developments in the field of healthcare; telehealth services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; telehealth services, namely, providing patients with health information relating to their medical condition; beauty and health care advice services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; Providing information on health and nutrition in the field of animal management; consulting services in the field of animal husbandry, medical and healthcare management, namely, medical research, development, analysis and identification of processes to efficiently raise individual animals; providing a website featuring information to retail customers of pharmacies over a global computer network with regard to health, wellness and pharmacy news; providing information, news and commentary in the field of current events relating to the healthcare industry and healthcare legislation and regulation; providing on-line information, news and commentary in the field of health and wellness relating to healthy diets and activities for male and female infants, children, teenagers, adults and seniors and to illnesses and treatments affecting them; pharmaceutical consultation; providing medical information

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 13, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCENCORA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCONSHOHOCKEN, PA 19428

Party NameCENCORA, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCONSHOHOCKEN, PA 19428

Party NameAmerisourceBergen Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressConshohocken, PA 19428

Trademark Events


Event DateEvent Description
Thursday, January 26, 2023NEW APPLICATION ENTERED
Monday, February 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 18, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, October 19, 2023ASSIGNED TO EXAMINER
Tuesday, October 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, October 24, 2023NON-FINAL ACTION E-MAILED
Tuesday, October 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Tuesday, January 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, April 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 18, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, April 18, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, May 9, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, May 9, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, May 9, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 9, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT